Influenza is associated with a substantial morbidity burden. Previous studies have reported that seasonal influenza epidemics and the recent 2009 H1N1 influenza pandemic were associated with annual hospitalization rates of 64 and 90 per 100,000 population in the United States (1, 2), respectively. These numbers were slightly lower than the corresponding estimates in the subtropical city of Hong Kong (102 and 133 hospitalizations per 100,000 population) (3). High-risk groups for influenza-associated disease burden, such as young persons or the elderly, persons with chronic medical conditions, and pregnant women, have long been identified and listed as priority groups for vaccination (4) . Recent studies suggested the possibility of a sex difference in influenza disease burden, as men and women differ in their susceptibility to influenza infections. However, these observational studies showed inconsistent results (5-9).
Moreover, some previous studies on sex difference counted pneumonia and influenza (P&I)-coded hospitalization, which was not specific to influenza infections and might have included hospitalization due to infections of bacteria or other respiratory viruses (5) . Other studies used laboratoryconfirmed influenza hospitalization, which was a specific measurement but likely to have underestimated the true burden (6, 8) . Influenza-associated hospitalization has been widely adopted by numerous disease burden studies to reliably capture all hospital admissions associated with influenza with or without laboratory diagnosis (10, 11) . This study aims to assess age and sex differences in the disease burden of influenza, by comparing age-and sex-specific excess hospitalizations associated with influenza A (subtypes A(H1N1), A(H3N2), and A(H1N1)pdm09) and B viruses, respectively.
METHODS

Data
Hospitalization records from 2004 to 2010 were obtained from the Hospital Authority, which covers 78% of total hospital bed-days in the entire Hong Kong SAR (12) . Weekly numbers of hospitalization for P&I were aggregated by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD9-CM), diagnosis codes 480-487. We considered 5 age groups: 0-5 (i.e., younger than 6 years), 6-17 (6 to younger than 18 years), 18-39 (18 to younger than 40), 40-64 (40 to younger than 65), and ≥65 (65 years or more), which were further broken down by sex. Annual age-and sex-specific population sizes were derived by linearly extrapolating the census or by census data for 2001, 2006 , and 2011 obtained from the Hong Kong Census and Statistics Department.
Weekly age-and sex-specific numbers of specimens positive for virology diagnosis, as well as the total specimens tested, were obtained from the Microbiology Laboratory of the Queen Mary Hospital, which tested around 21% of all specimens collected throughout Hong Kong. These virology diagnosis data have been demonstrated to represent the whole Hong Kong population (13, 14) . Nasopharyngeal aspirates were collected from inpatients to test for influenza A, influenza B, respiratory syncytial virus, adenovirus, and parainfluenza viruses by direct immunofluorescence tests. Influenza A-positive specimens were subsequently subtyped into seasonal subtypes A(H1N1) and A(H3N2) by viral culture, and reverse transcriptase polymerase chain reaction was conducted to test for the pandemic virus A(H1N1)pdm09 during the 2009 pandemic. Meteorology data of weekly temperature and relative humidity were obtained from the Hong Kong Observatory.
Statistical analysis
We applied a quasi-Poisson regression model to weekly numbers of P&I hospitalization of each age-sex group, with weekly age-and sex-specific numbers of specimens positive for A(H1N1), A(H3N2), A(H1N1)pdm09, and influenza B simultaneously added as proxy variables for the influenza type/subtype activities. Confounding factors of simultaneously circulating viruses (respiratory syncytial virus, adenovirus, and parainfluenza virus), long-term and seasonal trends, temperature, and relative humidity were adjusted for in our model. A typical form of the models is as follows: Y i; j;t ∼ quasi-Poissonðμ i; j;t ; φ i; j μ i; j;t Þ logðμ i; j;t Þ ¼ β 0;i; j þ β 1;i; j sH1N1 i; j;t þ β 2;i; j H3N2 i; j;t þ β 3;i; j pH1N1 i; j;t þ β 4;i; j FluB i; j;t þ β 5;i; j RSV i; j;t þ β 6;i; j Adeno i; j;t þ β 7;i; j Para i; j;t þ sðt; df ¼ kÞ
;
where i denotes age group (i = 0, 1, 2, 3, 4 for the age groups of 0-5, 6-17, 18-39, 40-64, and ≥65 years, respectively); j denotes sex ( j = 0 for male and j = 1 for female); Y i, j,t denotes weekly number of hospitalizations in age group i and sex j at week t (t = 1, 2, . . ., 364), which follows a Poisson distribution with overdispersion parameter ϕ i, j . sH1N1 i, j,t , H3N2 i, j,t , pH1N1 i,j,t , FluB i,j,t , RSV i,j,t , Adeno i,j,t , and Para i, j,t denote the proxy variables of weekly numbers of specimens that tested positive for A(H1N1), A(H3N2), A(H1N1)pdm09, influenza B, respiratory syncytial virus, adenovirus, and para-influenza virus, respectively. Natural cubic spline smoothing functions for long-term and seasonal trend s(t), temperature s(Temp t ), and relative humidity s(Hum t ) were added to adjust for confounding of these seasonal factors. The degrees of freedom (df ) for trends were up to 3 df per year, while those for temperature and relative humidity were set to 3 df for the whole period (3 Excess hospitalization rates associated with influenza virus type/subtype were calculated to assess the hospitalization burden for each age-sex group. Baseline numbers of hospitalizations were first calculated as the expected hospitalizations when the corresponding proxy variable was set to 0 (assuming that no influenza virus type/subtypes were circulating). Excess numbers of hospitalizations were then derived as the difference between the model-fit and baseline numbers of hospitalizations. The age-and sex-specific excess hospitalization rate was calculated as the excess number of hospitalizations divided by the annual population size each year. The 95% confidence intervals of excess hospitalization rates were estimated by the bootstrap method. The male-to-female ratios of excess rates (MFRs) were then calculated and their 95% confidence intervals were estimated by the delta method. The lower bound of the confidence interval was forced to 0 if the estimate was negative.
Model validation
The Hospital Authority established an electronic reporting system known as "eFlu" in response to the 2009 pandemic influenza for the period from May 1, 2009, to February 8, 2010 (15) . Reverse transcriptase polymerase chain reaction was routinely conducted to test for pandemic influenza infection in any patients with acute respiratory symptoms. The laboratory screening was intensively conducted so that the reported numbers from the eFlu database could be regarded as the lower boundary of the true burden. Hence, we compared the estimates from our models with the numbers reported by the eFlu data to validate our statistical models. 
Sensitivity analysis
To test for the robustness of our results, we conducted a sensitivity analysis by replacing the outcome of P&I hospitalization with the broader health outcome category of acute respiratory diseases. Similar to our main analysis, quasiPoisson regression models were fitted to weekly numbers of hospitalizations for acute respiratory diseases for each agesex combination.
The ethical approval of this study was obtained from the institutional review board of the University of Hong Kong/ Hospital Authority Hong Kong West Cluster (UV11-264). All statistical analyses were performed by using R, version 2.15.2 (R Foundation for Statistical Computing, Vienna, Austria) (16) .
RESULTS
Descriptive statistics
During the study period from 2004 to 2010, the annual total numbers of specimens positive for influenza ranged from 526 to 3,446, with more viruses isolated from men than women. A(H3N2) dominated (detected in more than half of influenza-positive specimens) in most of the study years Figure 1 ). Men had a higher rate of laboratory-confirmed influenza than women, except for A(H1N1) in the 40-64 age group and A(H1N1)pdm09 in the 18-64 age groups (Table 1) .
Excess hospitalization rate
Our model generally fit the observed data well for all agesex categories (Figures 2 and 3) . The excess hospitalization numbers from our model were slightly larger than eFlu numbers for both sexes under 65 years of age but were much larger for people aged 65 years or more. Excess rates of P&I hospitalization demonstrated a U-shape for both seasonal and pandemic influenza, with higher rates observed in the 0-5, 6-17, and ≥65 age groups and lower rates in the 18-39 and 40-64 age groups for both men and women (Table 2) . Compared with seasonal influenza of both types and subtypes, hospitalization rates associated with A(H1N1)pdm09 were slightly elevated in adults aged 18-64 years for both sexes (Table 2) .
Overall, men showed higher excess hospitalization rates than women, with MFRs larger than 1.0 in most age-sexdisease categories (Table 2 ). In the 0-5 age group, boys had higher excess hospitalization rates associated with all influenza types/subtypes than girls, with MFRs of 1.7, 1.4, 1.3, and 1.4 for A(H1N1), A(H3N2), A(H1N1)pdm09, and influenza B virus, respectively. A similar pattern of sex difference was found in people aged 6-17 years, with MFRs ranging from 1.1 to 2.4. In the 18-39 age group, women had higher excess hospitalization rates associated with A(H1N1), A(H1N1)pdm09, and influenza B, but the opposite was true for the excess hospitalization rate associated with A(H3N2). In the 40-64 age group, men had higher excess hospitalization rates associated with A(H1N1), A(H1N1)pdm09, and influenza B virus, while no sex heterogeneity was found for A(H3N2). In people aged 65 years or more, no sex difference was found for the seasonal influenza A subtypes A(H1N1) and A(H3N2) as the MFRs were equal to 1.0, but men showed an excess hospitalization rate that was 11% lower than that of women for A(H1N1)pdm09 and 60% higher for influenza B virus. The MFRs were not statistically significant for all age-virus categories.
The sensitivity analysis showed a similar pattern of the MFR to the main results (data not shown). Boys aged below 18 years had a higher excess hospitalization rate than girls, with MFRs all greater than 1. The MFRs for adults were all equal to or higher than 1.0 except for A(H1N1)pdm09 in persons aged 18-39 years and 65 years or more and influenza B in adults aged 18-39 years. The sex difference of excess hospitalization associated with influenza was not statistically significant. 
DISCUSSION
We found that boys younger than 18 years of age tended to have higher excess hospitalization rates than girls for seasonal influenza, which was consistent with previous findings from Canada and Denmark, as well as the World Health Organization report (5, 17, 18) . Sex differences in influenzaassociated hospitalization burden could be the result of differences between men and women in terms of host susceptibility, exposure risk, health-seeking behaviors, and immune response to influenza vaccination and antiviral therapies (19) (20) (21) (22) . Boys tend to be more active than girls, thereby having a higher risk of exposure to environmental pathogens (including influenza) through close contact with infected people or touch of contaminated surface (23) . Previous studies also found that boys had a weaker immune response against influenza infections than girls (24) , but this difference gradually vanishes as they grow into adults (25) . This could probably be supported by our findings that the MFR was close to 1 in adults. Consistent with the findings from Canada and Argentina (5, 26), our study findings showed some evidence of higher hospitalization risks associated with seasonal influenza in older men than older women, although the difference was not statistically significant. The reason could be the higher prevalence of chronic conditions in older men (27) , such as respiratory diseases, cardiovascular diseases, and metabolic disorders, which could greatly increase the susceptibility of influenza infection. Moreover, previous studies also found that women demonstrated a better compliance with nonpharmaceutical intervention measures such as hand hygiene (28) , which could have effectively reduced the risk of viral infections (29) . Sex steroid hormones have long been identified to modulate host immunocompetence, or more specifically androgens may lower and estrogens may enhance several aspects of immunity (30) . Experiments on mice showed that males generally exhibited lower humoral and cell-mediated immune responses than females after viral infection (31) . In addition, sex steroid hormones could affect cell-mediated immune responses by regulating disease resistance genes encoding immunoglobulin proteins (32, 33) . Numerous studies have revealed that hemagglutinin inhibition titers are consistently higher in women than men after seasonal influenza vaccination, suggesting a better protection against influenza in women (24, 34) . Other explanations include a higher smoking prevalence and a lower vaccination rate in men in Hong Kong (35) (36) (37) . Although we did not find strong evidence of age and sex differences in the influenza-associated morbidity burden, the hypotheses that men and women may differ in host susceptibility, exposure risk, health-seeking behavior, and immune response to influenza vaccination and antiviral therapies still warrant further investigation. The 2009 H1N1 pandemic was characterized with an age shift toward young people and a relatively low case-fatality risk compared with previous pandemics (3, 38) . However, studies on sex difference found inconsistent patterns across regions. A Canadian study found that the relative risk of death in adult women is 1.5 times the risk in men (39) , while an Australian study reported that 58% of fatal cases were from men (8) . Disease burden studies for the 2009 pandemic revealed a trend for more women than men being hospitalized in Canada, Mexico, and New Zealand (39) (40) (41) , but these studies may be confounded by age, and none of these studies reported the male-female difference across age. Our study indicated different male-female ratios for hospitalization rates associated with the 2009 pandemic in different age groups, with higher rates found in men aged 0-5, 6-17, and 40-64 years, while higher rates were found in women aged 18-39 and 65 years or more. Most of the available studies on children found a higher hospitalization burden associated with the 2009 influenza pandemic in boys (42, 43) and speculated that the mechanism for girls' having a higher immune response to the novel pandemic H1N1 virus is similar to that for seasonal influenza. Women of reproductive age have a higher risk of hospitalization for the 2009 pandemic influenza than men, which is consistent with results from previous studies (44, 45) . The enhanced risk of influenza-associated hospitalization in pregnant women is likely attributable to the contradictory demands for the maternal immune system to adapt to pregnancy and to simultaneously mount an immune response to clear the influenza virus infection (46) . For the elderly population, our results should be interpreted with caution, as the confidence intervals for the MFRs are wide because of the relatively short pandemic period. Nevertheless, our MFR estimate of 0.9 is consistent with the American estimate of 0.77 (47) but contradicts the estimates from South Korea and Japan (MFR > 1) (42, 43) . There is no good explanation for the higher morbidity burden associated with pandemic influenza in the elderly women in our study, but we speculated that this could be due to the higher prevalence of obesity and diabetes, both of which were identified as risk factors of the 2009 pandemic (18) , in older women than in older men. It has been reported that, in year 2000, the prevalence of obesity was 42.1% in women aged 65 years or more, slightly higher than the prevalence of 36.6% in men residing in Hong Kong (48) . The prevalence of diabetes in women was also higher than that in men (29.4% vs. 22.3% in year 1996) for those aged 65-74 years (49) . The association of diabetes mellitus and obesity (and probably other risk factors) with pandemic influenza hospitalization and the underlying mechanism of sex difference warrants detailed further investigation.
We assessed age and sex differences of influenza disease burden by comparing age-and sex-specific, influenzaassociated hospitalizations estimated from quasi-Poisson models. Our previous study has demonstrated that the Poisson regression model could provide valid and reliable estimates for influenza-associated disease burden (10) . In this study, we used a proxy variable of age-and sex-specific isolate number, which provides estimates closer to the true hospitalization rates than the other proxies (e.g., all-ages numbers or proportions of positive specimens) (50) . However, we should be cautious that the weekly numbers of positive isolates for influenza type/subtype become small numbers after stratifying by age and sex, which may affect the statistical power yielding nonsignificant results. In this study, we used current weekly meteorological values rather lagged meteorological values, because the time scale used is weekly and we think the influence of meteorological factors on severe health outcome, such as hospital admissions, should occur within the same week. The estimates from the Poisson regression model were larger than the laboratory-confirmed cases, which is not surprising since the former could also capture those hospitalized cases that are asymptomatic of influenza infections or not detectable by routine laboratory testing in addition to laboratory-confirmed cases. The pattern of sex differences was similar between laboratory-confirmed cases and excess hospitalization rates for most age-virus-disease categories, except that people aged 65 years or more were less likely to be diagnosed as having pandemic A(H1N1)pdm09. This inconsistency probably has reflected an underreporting of influenza hospitalizations among the older population during the 2009 pandemic.
There are several limitations to our study. First, the short period of the pandemic yielded relatively wide 95% confidence intervals for most estimates, making it difficult to assess age and sex differences in the burden associated with the pandemic. Second, our study cannot totally rule out the impact of changing the hospital admission threshold, a clinician's coding practice, and populations' health-seeking behavior on the disease burden of influenza, especially during the 2009 H1N1 pandemic. Third, our study did not considered the impact of influenza vaccination coverage on the sex difference of influenza-associated hospitalization. However, vaccination coverage is low in the general population of Hong Kong, although this might have little impact on our findings.
As a conclusion, boys tended to have higher excess hospitalization rates associated with influenza viruses than girls. Adult men tended to have higher risks of excess hospitalization associated with seasonal and pandemic influenza than adult women, except that women of reproductive age and older age had higher risks of excess hospitalization associated with pandemic influenza than men, although these findings should be interpreted with caution and warrant further investigation. Overall, our findings showed some limited evidence of age and sex differences in the influenza-associated morbidity burden of the subtropical city, Hong Kong.
